Parkside Financial Bank & Trust’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$695 Hold
40
﹤0.01% 2468
2025
Q4
$754 Hold
40
﹤0.01% 2438
2025
Q3
$582 Buy
40
+15
+60% +$214 ﹤0.01% 2501
2025
Q2
$489 Hold
25
﹤0.01% 2566
2025
Q1
$444 Buy
+25
New +$538 ﹤0.01% 2482

Other funds holding CDNA

Parkside Financial Bank & Trust's CDNA Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its CareDx (CDNA) position steady in Q1 2026 at 40 shares worth $695. The position accounts for ﹤0.01% of the portfolio, ranked #2468.

Parkside Financial Bank & Trust first reported a position in CDNA in Q1 2025 and has held it in 5 quarters since. The position peaked at $754 in Q4 2025. 190 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.

  • Parkside Financial Bank & Trust held 40 shares of CareDx worth $695 as of Q1 2026.
  • Parkside Financial Bank & Trust left its CareDx share count unchanged in Q1 2026.
  • CareDx made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2468 holding.
  • Parkside Financial Bank & Trust first reported a position in CareDx in Q1 2025 and has held it in 5 quarters since.
  • Parkside Financial Bank & Trust's CareDx position peaked at $754 in Q4 2025.
  • 190 funds tracked by Wall St. Rank held CareDx as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.